A new School of Management study found field tests better predicted donor behavior than industry experts or academic models.

The work led by UB bioengineers Ruogang Zhao and Yun Wu may help discover new drugs to treat pulmonary fibrosis, a severe lung disease that has no cure.

The study also has implications for other neurological disorders, including multiple sclerosis and Parkinson’s disease.

Household members of anyone who recently tested positive for COVID-19 are being recruited for Regeneron’s national clinical trial of the investigational antibody cocktail REGN-COV2.  

Combining light and sound adds depth information that boosts the security to this new approach to biometric authentication.

Researchers suggest improved parental leave policies, higher pay and more equal distribution of household labor.

A UB study has found that the rare, debilitating condition hyperemesis gravidarum can be effectively treated with the seizure drug gabapentin.

The dental school faculty member was recognized for two editorials he published in dental journals or periodicals.  

The partnership is working to advance affordable, new antivirals and vaccines for neglected infectious diseases such as the dengue, Zika and Chikungunya viruses.

With a $3.7 million NIH grant, the team will develop advanced flexible and wearable imaging hardware, fast imaging techniques and imaging sequences.